Topics

Latest "Pelvic Floor Muscle Training Versus Treatment Inactive Control" News Stories

02:13 EST 20th February 2020 | BioPortfolio

Here are the most relevant search results for "Pelvic Floor Muscle Training Versus Treatment Inactive Control" found in our extensive news archives from over 250 global news sources.

More Information about Pelvic Floor Muscle Training Versus Treatment Inactive Control on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Pelvic Floor Muscle Training Versus Treatment Inactive Control for you to read. Along with our medical data and news we also list Pelvic Floor Muscle Training Versus Treatment Inactive Control Clinical Trials, which are updated daily. BioPortfolio also has a large database of Pelvic Floor Muscle Training Versus Treatment Inactive Control Companies for you to search.

Showing "Pelvic Floor Muscle Training Versus Treatment Inactive Control" News Articles 1–25 of 24,000+

Thursday 20th February 2020

Efficient Assistance, YITU AI Aids Epidemic Prevention and Control of COVID-19 Outbreak

Since the outbreak of COVID-19, Yitu Healthcare responded quickly and launched an operation of multiple departments. The main R & D team sacrificed their vacations, worked around the clock for several consecutive days and finally completed the development of the Intelligent Evaluation System of Chest CT for COVID-19 in a very short period of time. The system was launched during the Chinese Sp...


Polyphor announces progress of the Phase III immuno-oncology program with balixafortide. Renewed strategy in advancing antibiotics and oncology research and pipeline

Polyphor AG / Key word(s): Miscellaneous 20-Feb-2020 / 07:00 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 KR The issuer is solely responsible for the content of this announcement. Allschwil, Switzerland, February 20, 2020 Polyphor announces progress of the Phase III immuno-oncology program with balixafortide. Renewed strategy in advancing antibiotics and oncology res...

Relapsing Multiple Sclerosis Pricing Market Access and Landscape 2026 [Published by First View Insight] Prices from USD $2125

Firstview Insight's Relapsing Multiple Sclerosis Pricing Market Access and Landscape 2026 provides country specific insights in order to estimate market potential for Relapsing Multiple Sclerosis based on the pricing and reimbursement scenario and perceived value drivers in different market archetypes. It gives a detailed picture of the disease landscape and unmet needs of different stakeholde...


Breath Therapeutics, a Zambon company, initiates BOSTON-3 and BOSTON-4, two additional clinical studies for the treatment of bronchiolitis obliterans syndrome (BOS)

- Liposomal Cyclosporine A for Inhalation (L‑CsA‑i) is advancing in clinical studies for the treatment for bronchiolitis obliterans syndrome (BOS) - BOS is a devastating rare lung disease associated with high mortality - An estimated 30,000 lung transplant and allogeneic hematopoietic stem cell transplant (alloHSCT) recipients worldwide are affected by BOS1 - BOSTON-1 and BOSTON-2 are p...

Wednesday 19th February 2020

Terns Announces Positive Data from Phase I Trial of NASH Candidate

Terns Pharma, a Shanghai-San Francisco biopharma, reported TERN-101, a potential treatment for NASH, was well tolerated and seemed to engage its FXR target in a US Phase I trial. The trial was a randomized, double-blind, placebo-controlled study designed to evaluate safety, pharmacokinetics, pharmacodynamics and plasma biomarkers of FXR pathway activation. It enrolled 36 healthy participants who r...

Global Arachidonic Acid Market 2020-2024 | 7% CAGR Projection Through 2024 | Technavio

The global arachidonic acid market is expected to post a CAGR of almost 7% during the period 2020-2024, according to the latest market research report by Technavio. Request a free sample report This press release features multimedia. View the full release here: https://www.businesswire.com

[Articles] Contact isolation versus standard precautions to decrease acquisition of extended-spectrum β-lactamase-producing Enterobacterales in non-critical care wards: a cluster-randomised crossover trial

Contact isolation showed no benefit when added to standard precautions for controlling the spread of ESBL-E on non-critical care wards with extensive surveillance screening.

Spruce Biosciences Raises $88 Million in Series B Financing, co-led by Omega Funds and Abingworth

- Proceeds to advance development of Tildacerfont in Congenital Adrenal Hyperplasia and other indications - Existing Investors Novo Holdings and RiverVest Venture Partners support the deal with new Investors HealthCap Partners, Rock Springs Capital, Aisling Capital, Surveyor Capital (a Citadel company) and Sands Capital joining the syndicate Spruce Biosciences today announced it has raised $8...

Twist Bioscience Announces Pricing of Upsized $130.0 Million Public Offering of Common Stock

Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced the pricing of an underwritten public offering of 4,642,857 shares of its common stock at a price to the public of $28.00 per share. The gross proceeds of the offering to Twist before deducting the underwriting discount...

20172025 World Smart Fabrics and Textiles Market Research Report by Product Type, EndUser / Application and Regions / Countries [Published by HeyReport] Prices from USD $2380

SummarySmart textiles are fabrics that have been designed and manufactured to include technologies that provide the wearer with increased functionality Smart textiles are defined as textiles that can sense and react via an active control mechanism to environmental conditions or stimuli from mechanical, thermal, chemical, electrical or magnetic sources.This report includes market status and forecas...

FETO therapy produces favorable outcomes when fetal and maternal care are highly coordinated

Researchers from The Johns Hopkins Center for Fetal Therapy report new evidence that fetuses with severe congenital diaphragmatic hernia, a rare but life-threatening, lung-damaging condition, experience a significantly high rate of success for the fetal treatment known as FETO, if they and their mothers receive coordinated and highly experienced care in the same expert setting.

Storytelling, music and song: how psychosocial approaches to dementia change lives

While medicines can be an important part of dementia treatment, there are doubts over whether they provide meaningful benefits for patients. As a result, emphasis is being placed on non-pharmacological approaches, some of which have had a transformative impact on the lives of patients with dementia.

Baby born from egg matured in the lab and frozen

French fertility doctors have announced what is claimed to be the first baby to be born from an immature egg that was matured in the laboratory, frozen, then thawed and fertilised years later — a breakthrough that has now been documented in the journal Annals of Oncology. Professor Michaël Grynberg, Head of the Department of Reproductive Medicine and Fertility Preservation at the Antoine Bécl...

Bioengineers create light-controllable CAR T cells for cancer immunotherapy

Bioengineers at the University of California San Diego have developed a control system that could make CAR T-cell therapy safer and more powerful when treating cancer.

Researchers in #Japan identify a new quality control system that cells use to remove damaged and potentially toxic proteins—including amyloid β that is associated with #Alzheimers disease—from the extracellular space: http://ow.ly/WMC750yqnhq pic.t

Researchers in #Japan identify a new quality control system that cells use to remove damaged and potentially toxic proteins—including amyloid β that is associated with #Alzheimers disease—from the extracellular space: http://ow.ly/WMC750yqnhq  pic.twitter.com/Jd8HXzCnNk

20172025 World Laboratory Water Purifier Market Research Report by Product Type, EndUser / Application and Regions / Countries [Published by HeyReport] Prices from USD $2380

SummaryLaboratory water purifier is used to remove impurities, salt ions, bacteria and viruses from water in the laboratory. The processes include capacitive deionization, reverse osmosis, carbon filtering, microfiltration, ultrafiltration, ultraviolet oxidation, or electro deionization.Purified water is a common requirement within all laboratories, particularly research, infection control and pat...

Teva Drug Fails to Beat Placebo in Pediatric Tourette Patient Trials

A Teva Pharmaceutical drug in testing as a treatment for tics in pediatric patients with moderate-to-severe Tourette syndrome has failed two late-stage trials. Israel-based Teva (NYSE: TEVA) said Wednesday that the drug, deutetrabenazine, didn’t beat a placebo in reducing motor and phonic tics—the main goals of the Phase 2/3 and Phase 3 trials. Those signs […]

Rx List Price Inflation Penalty Endorsed By US HHS Secretary

Senate Finance Committee’s approach to penalize companies for raising WAC list prices is not a ‘price control,’ but a reasonable...   

Optogenetic control of single mRNA spatiotemporal dynamics

Patient satisfaction and quality of life similar across all appendicitis treatments

A new study published in the journal JAMA Surgery in February 2020 shows that patients with acute appendicitis that were successfully treated either by antibiotics or by appendectomy had identical satisfaction with their treatment and identical quality of life over the long term. The patients who were first treated conservatively and then had appendectomy had lower satisfaction rates.

BioOhio to Host Regional Bioscience Career Fairs Throughout Ohio

As another example of Ohio’s commitment to attracting top talent and public-private partnerships (P3), three cities: Gahanna, Mason, and Mentor, in partnership with BioOhio, Ohio’s bioscience trade association, announced each city will host a Regional Bioscience Career Fair during the week of February 24th, 2020. Career Fair Dates, Times, & Locations: Central Ohio Regional Career Fai...

Global Marine Biotechnology Market 2020-2024 | Evolving Opportunities With Aker BioMarine AS and BASF SE | Technavio

The marine biotechnology market is poised to grow by USD 2.5 billion during 2020-2024, progressing at a CAGR of over 8% during the forecast period. Request free sample pages This press release features multimedia. View the full release here:

UPM joins Finnish research consortium to advance extracellular vesicle technologies

UPM has joined a newly formed Finnish research consortium that plans to use extracellular vesicles to develop novel nano-biotechnological solutions for the early diagnostics and treatment of severe progressive diseases.

FDA Grants Priority Review to Selinexor for Relapsed/Refractory DLBCL

The FDA has granted a priority review designation to a supplemental new drug application for selinexor as a treatment for adult patients with relapsed/refractory diffuse large B-cell lymphoma, not otherwise specified, who have received ≥2 prior therapies.

Emerging Combos Lead to More Questions, Research Efforts in Advanced HCC

James J. Harding, MD, discusses the evolving treatment landscape in frontline hepatocellular carcinoma and ongoing trials that may revolutionize the space.


Quick Search

News Quicklinks